Allscripts (MDRX:Nasdaq)
Enviado: 30/12/2004 17:14Thursday, December 30, 2004 11:12 a.m. EST
Dear Subscriber to TheStreet.com Stocks Under $10,
Shares of Allscripts (MDRX:Nasdaq) are trading 3% higher
this morning to $10.70. We aren't taking any action on his
move, but want to give you readers a look at what's
driving the action.
WR Hambrecht is reporting Allscripts has signed a deal
with California-based Sharp Healthcare. Based on the
research note, we expect a press release to be put out
early in January.
Hambrecht estimates the deal to be worth $4 million, which
would be Allscripts' largest to date. It will provide the
company's Touchscripts product to seven hospitals and 300
physicians within the Sharp system. These doctors will now
have the option of running their practice with a greater
emphasis on information technology. Hambrecht also
estimates Sharp could provide a 5-cent boost to
Allscripts' bottom-line estimate of 21 cents in 2005.
Touchscripts automates physician activities like writing
prescriptions and ordering lab tests through the use of a
personal digital assistant (PDA).
President Bush has been outspoken about the need to
implement technology in the physician's office to lower
health-care costs. We remain bullish on Allscripts and
believe the company stands to benefit from this big
opportunity, as more physicians turn to Allscripts'
technology as they become more familiar and comfortable
with the company's products.
Regards,
The TSC Investment Team
Dear Subscriber to TheStreet.com Stocks Under $10,
Shares of Allscripts (MDRX:Nasdaq) are trading 3% higher
this morning to $10.70. We aren't taking any action on his
move, but want to give you readers a look at what's
driving the action.
WR Hambrecht is reporting Allscripts has signed a deal
with California-based Sharp Healthcare. Based on the
research note, we expect a press release to be put out
early in January.
Hambrecht estimates the deal to be worth $4 million, which
would be Allscripts' largest to date. It will provide the
company's Touchscripts product to seven hospitals and 300
physicians within the Sharp system. These doctors will now
have the option of running their practice with a greater
emphasis on information technology. Hambrecht also
estimates Sharp could provide a 5-cent boost to
Allscripts' bottom-line estimate of 21 cents in 2005.
Touchscripts automates physician activities like writing
prescriptions and ordering lab tests through the use of a
personal digital assistant (PDA).
President Bush has been outspoken about the need to
implement technology in the physician's office to lower
health-care costs. We remain bullish on Allscripts and
believe the company stands to benefit from this big
opportunity, as more physicians turn to Allscripts'
technology as they become more familiar and comfortable
with the company's products.
Regards,
The TSC Investment Team